Security key
48576U106
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)
CUSIP: 48576U106
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 22,658,403
- Total 13F shares
- 80,450,419
- Share change
- -7,107,303
- Total reported value
- $144,011,333
- Put/Call ratio
- 42%
- Price per share
- $1.79
- Number of holders
- 133
- Value change
- -$18,617,679
- Number of buys
- 71
- Number of sells
- 64
Report period
Q2 2023
Institutions
133
Top holders
10
KPTI full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Karyopharm Therapeutics Inc. SEC filings
Karyopharm Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48576U106
Recent filing periods:
Top shareholders of KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| STATE STREET CORP |
13F
|
Company |
45%
|
10,175,989
|
$39,582,783 | — | 31 Mar 2023 | |
| Avidity Partners Management LP |
13F
|
Company |
43%
|
9,633,911
|
$37,475,914 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
40%
|
9,072,188
|
$35,290,810 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
33%
|
7,503,836
|
$29,189,922 | — | 31 Mar 2023 | |
| Palo Alto Investors LP |
13F
|
Company |
25%
|
5,675,876
|
$22,079,158 | — | 31 Mar 2023 | |
| Rubric Capital Management LP |
13F
|
Company |
20%
|
4,441,056
|
$17,275,708 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
16%
|
3,602,460
|
$14,013,570 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
13%
|
2,847,389
|
$11,076,344 | — | 31 Mar 2023 | |
| Opaleye Management Inc. |
13F
|
Company |
12%
|
2,810,800
|
$10,934,012 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
9.5%
|
2,157,781
|
$8,393,768 | — | 31 Mar 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
8.8%
|
1,984,906
|
$7,721,284 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
7.8%
|
1,778,532
|
$6,918,000 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
7.8%
|
1,771,733
|
$6,892,041 | — | 31 Mar 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
7.3%
|
1,644,934
|
$6,398,793 | — | 31 Mar 2023 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
6.8%
|
1,541,426
|
$5,996,147 | — | 31 Mar 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
6.8%
|
1,535,026
|
$5,496,142 | — | 31 Mar 2023 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
6.6%
|
1,500,000
|
$5,835,000 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
6.5%
|
1,469,147
|
$5,714,982 | — | 31 Mar 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
4.7%
|
1,075,074
|
$4,182,038 | — | 31 Mar 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
4%
|
913,301
|
$3,552,741 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
3.6%
|
824,749
|
$3,208,273 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.2%
|
735,700
|
$2,862,000 | — | 31 Mar 2023 | |
| CITIGROUP INC |
13F
|
Company |
3.2%
|
730,027
|
$2,839,805 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
3.2%
|
726,690
|
$2,826,823 | — | 31 Mar 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
2.6%
|
593,805
|
$2,309,901 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.4%
|
549,607
|
$2,137,971 | — | 31 Mar 2023 | |
| Altium Capital Management LLC |
13F
|
Company |
2.2%
|
505,781
|
$1,967,488 | — | 31 Mar 2023 | |
| Tejara Capital Ltd |
13F
|
Company |
2.2%
|
501,562
|
$1,951,076 | — | 31 Mar 2023 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
2.1%
|
481,696
|
$1,873,797 | — | 31 Mar 2023 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
2%
|
460,979
|
$1,793,208 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
2%
|
454,466
|
$1,767,873 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.8%
|
401,500
|
$1,561,835 | — | 31 Mar 2023 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.7%
|
380,000
|
$1,478,000 | — | 31 Mar 2023 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
1.6%
|
369,605
|
$1,437,763 | — | 31 Mar 2023 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.3%
|
300,000
|
$1,167,000 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.3%
|
295,184
|
$1,148,266 | — | 31 Mar 2023 | |
| Birchview Capital, LP |
13F
|
Company |
1.3%
|
291,332
|
$1,133,000 | — | 31 Mar 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.1%
|
257,856
|
$1,003,059 | — | 31 Mar 2023 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
1.1%
|
240,000
|
$933,600 | — | 31 Mar 2023 | |
| CAXTON ASSOCIATES LP |
13F
|
Company |
1%
|
235,626
|
$916,585 | — | 31 Mar 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1%
|
234,049
|
$910,450 | — | 31 Mar 2023 | |
| Swiss National Bank |
13F
|
Company |
1%
|
231,550
|
$900,730 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.98%
|
222,711
|
$866,346 | — | 31 Mar 2023 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.87%
|
197,433
|
$768,014 | — | 31 Mar 2023 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.85%
|
192,678
|
$749,517 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.84%
|
190,668
|
$742,000 | — | 31 Mar 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.83%
|
187,450
|
$729,181 | — | 31 Mar 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.78%
|
177,830
|
$691,759 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.74%
|
167,641
|
$652,123 | — | 31 Mar 2023 | |
| PROFUND ADVISORS LLC |
13F
|
Company |
0.74%
|
167,517
|
$651,641 | — | 31 Mar 2023 |
Institutional Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) as of Q2 2023
As of 30 Jun 2023,
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) was held by
133 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
80,450,419 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Avidity Partners Management LP, Palo Alto Investors LP, CITADEL ADVISORS LLC, MARSHALL WACE, LLP, ExodusPoint Capital Management, LP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and Opaleye Management Inc..
This page lists
133
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
128
Q2 2023 holders
133
Holder diff
5
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.